Athersys, Inc. · Cleveland, OH United States (NASDAQ: ATHX)
| 3201 Carnegie Ave. | Phone: 216-431-9900 |
| Cleveland, OH | Fax: 216-361-9495 |
| 44115 | |
| United States | 
Map This Company |
Athersys, Inc. Rankings
More Companies in These Related Industries: Pharmaceutical Preparation MfgCompany Description
Biotechnology is all the RAGE at Athersys. The development-stage company uses its Random Activation of Gene Expression (RAGE) technology to scan the human genome, identify proteins with specific biological functions, and link those protein functions with gene structures (functional genomics). It is also developing therapies for oncology and vascular applications based on its MultiStem technology, which uses stem cells from adult bone marrow. The firm plans to leverage its technologies by partnering with other biotechs and drugmakers, but it also aims to develop its own proprietary drugs. It counts
Athersys, Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - NASDAQ: ATHX Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2010 Employees | 44 |
Executives
14 executives listed for Athersys, Inc.'s Cleveland, OH location.
| Chairman and CEO | Gil Van Bokkelen | |
|---|---|---|
| President, COO, and Secretary | William Lehmann | |
| VP Finance | Laura Campbell |